🧬Neuroscience & CNS
Companies developing treatments for neurological and psychiatric disorders including Alzheimer's, Parkinson's, and depression.
Market Cap$225.1B
1D+0.21%
Companies657
Public Cos94
SECTOR MARKET CAP
$225.1B+48987.5%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | Belgium | $53.1B | UCB.VI |
| 2 |  | Japan | $34.5B | 4578.T |
| 3 |  | United States | $29.2B | BIIB |
| 4 |  | United States | $16.1B | NBIX |
| 5 |  | United States | $12.8B | AXSM |
| 6 |  | United States | $10.7B | CYTK |
| 7 |  | United States | $8.3B | PRAX |
| 8 |  | Japan | $6.8B | 4523.T |
| 9 |  | Hong Kong | $6.4B | RGC |
| 10 |  | Denmark | $6.3B | HLUN-B.CO |
| 11 |  | Canada | $5.2B | XENE |
| 12 |  | Sweden | $2.9B | BIOA-B.ST |
| 13 |  | Netherlands | $2.9B | QURE |
| 14 |  | United States | $2.6B | TRVI |
| 15 |  | United States | $2.3B | BHVN |
| 16 |  | United States | $1.9B | HRMY |
| 17 |  | United States | $1.9B | TSHA |
| 18 |  | United States | $1.9B | RAPP |
| 19 |  | United States | $1.8B | AMLX |
| 20 |  | Switzerland | $1.8B | IDIA.SW |